NEW YORK, May 26, 2011 /PRNewswire/ -- Aeolus
Pharmaceuticals, Inc. (OTCQB: AOLS) today announced that
John McManus, the company's Chief
Executive Officer, will presenting at
RetailInvestorConferences.com.
|
DATE:
|
June 2nd, 2011
|
|
|
TIME:
|
2:00 PM EDT
|
|
|
LINK:
|
www.retailinvestorconferences.com
> Click the red "register/
watch event now" button.
|
|
|
|
This will be a live, interactive online event where investors
are invited to ask the company questions in real-time both in the
presentation hall as well as the company's "virtual trade booth."
If attendees are not able to join the event live in real-time, an
on-demand archive will be available for 90 days.
It is recommended that investors pre-register to save time and
receive event updates.
About Aeolus Pharmaceuticals
Aeolus Pharmaceuticals is developing a new class of catalytic
antioxidant compounds that protects healthy tissue from the
damaging effects of radiation. Its first compound, AEOL 10150, is
being developed for oncology indications, where it is used in
combination with radiation therapy. It is also being developed,
with up to $140 million in funding by
the US Government, as a medical countermeasure against chemical and
radiological weapons, where its initial target indications are as a
protective agent against the effects of acute radiation syndrome
and delayed effects of acute radiation exposure. Aeolus' strategy
is to leverage the substantial investment in toxicology,
manufacturing, and preclinical and clinical studies made by US
Government agencies in AEOL 10150 to efficiently develop the
compound for use in oncology.
About RetailInvestorConferences.com:
RetailInvestorConferences.com, created by BetterInvesting
(NAIC), PR Newswire and MUNCmedia, is the first monthly
virtual investor conference series that provides an interactive
forum for presenting companies to meet directly with retail
investors using a graphically-enhanced online platform.
Designed to replicate the look and feel of location-based
investor conferences, Retail Investor Conferences unites PR
Newswire's leading-edge online conferencing and investor
communications capabilities with BetterInvesting's extensive retail
investor audience network and MUNCmedia's sophisticated retail
investor targeting.
SOURCE Aeolus Pharmaceuticals
